| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 270.00▲ | 267.78▲ | 267.96▲ | 252.39▲ | 253.22▲ |
| MA10 | 269.49▲ | 267.31▲ | 267.62▲ | 241.59▲ | 256.43▲ |
| MA20 | 268.14▲ | 266.91▲ | 266.42▲ | 246.47▲ | 253.61▲ |
| MA50 | 267.35▲ | 257.87▲ | 244.51▲ | 255.72▲ | 261.73▲ |
| MA100 | 267.27▲ | 243.54▲ | 244.80▲ | 251.57▲ | 238.40▲ |
| MA200 | 266.00▲ | 245.02▲ | 249.45▲ | 263.08▲ | 230.97▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.274▲ | -0.402▼ | -0.731▼ | 3.664▲ | 0.473▲ |
| RSI | 79.838▲ | 67.190▲ | 70.038▲ | 63.422▲ | 54.933▲ |
| STOCH | 91.515▲ | 71.022 | 70.929 | 55.096 | 40.419 |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -2.858▲ | -27.140 |
| CCI | 126.480▲ | 268.099▲ | 170.809▲ | 116.991▲ | 70.080 |
| ▲ PSAR&MOM | $PEN PSAR Switch Up + Momentum | Set Alert |
| ▲ RSI&MACD | $PEN MACD cross and RSI above 55 | Set Alert |
| ▲ RSI&VOL | $PEN RSI Cross Up and Volume | Set Alert |
| RSI | $PEN RSI(14) Crossed Above 50 | Set Alert |
| ▲ MACD | $PEN MACD(12,26,9) Crossed Above Signal Line | Set Alert |
| MA | $PEN Price Crossed Above MA(200) | Set Alert |
| MA | $PEN Price Crossed Above MA(50) | Set Alert |
| MA | $PEN Price Crossed Above MA(26) | Set Alert |
| MA | $PEN Price Crossed Above MA(13) | Set Alert |
| MA | $PEN Price Crossed Above MA(7) | Set Alert |
| ▲ GAP | $PEN Open Gap Up %5 | Set Alert |
| ▲ GAP | $PEN Open Gap Up %3 | Set Alert |
| ▲ GAP | $PEN Open Gap Up %2 | Set Alert |
| ▲ BREAK | $PEN Price Breaks 10 Days High | Set Alert |
|
Saturday, November 08, 2025 05:29 AM
A week ago, Penumbra, Inc. ( NYSE:PEN ) came out with a strong set of third-quarter numbers that could potentially ...
|
|
Friday, November 07, 2025 05:23 AM
Q3 2025 Earnings Call Transcript November 5, 2025 Penumbra, Inc. beats earnings expectations. Reported EPS is $0.97, expectations were $0.9. Operator: Ladies and gentlemen, good afternoon. My name is ...
|
|
Wednesday, November 05, 2025 02:12 PM
Medical device company Penumbra (NYSE:PEN) reported Q3 CY2025 results , with sales up 17.8% year on year to $354.7 million. Its non-GAAP profit of $0.97 per share was 5.3% above analysts’ consensus ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/11/25 | 266.60 | 270.80 | 262.94 | 270.55 | 535,962 |
| 07/11/25 | 264.56 | 270.00 | 259.14 | 266.19 | 636,009 |
| 06/11/25 | 259.79 | 272.00 | 258.59 | 264.61 | 1,111,215 |
| 05/11/25 | 232.00 | 236.325 | 225.52 | 225.54 | 593,207 |
| 04/11/25 | 227.58 | 235.587 | 227.365 | 235.08 | 566,777 |
| 03/11/25 | 225.60 | 226.505 | 221.26 | 226.19 | 494,458 |
| 31/10/25 | 230.92 | 231.655 | 225.46 | 227.37 | 575,731 |
| 30/10/25 | 233.57 | 236.92 | 229.95 | 231.54 | 336,675 |
| 29/10/25 | 234.26 | 239.01 | 228.72 | 233.37 | 492,151 |
| 28/10/25 | 246.34 | 247.7699 | 232.51 | 235.50 | 612,758 |
|
|
||||
|
|
||||
|
|